News in Numbers

Valneva sold a priority review voucher, which it received when its chikungunya vaccine, Ixchiq, got FDA approval in November 2023, to an undisclosed party for €95m ($103m).

AbbVie reported $54.32bn in net FY2023 revenues, a 6.4% drop compared to the previous year.

AstraZeneca is investing $300m in a facility in Rockville, Maryland, marking a significant step in launching its cell therapy platforms in the US.

The European Medicines Agency has selected two participants developing gene therapies— Berlin Center for Advanced Therapies and Fondazione Telethon in a pilot program to encourage non-commercial developers of advanced therapy medicinal products.

As per the World Health Organization, there were an estimated 20 million new cancer cases and 9.7 million deaths, in 2022.